Exploratory analyses revealed exenatide significantly reduced heavy drinking days and total alcohol intake in a subgroup of obese patients. Senior author Professor Anders Fink-Jensen told medscape.com: Something is happening in the brain, and activation of the reward centre is hampered by the GLP-1 compound. And he noted: If patients with AUD already fulfill the criteria for semaglutide (or other GLP-1 analogs) by having type 2 diabetes and/or a Body Mass Index (BMI) over 30kg/m2, they can of course use the compound right now. Professor Fink-Jensens team is also beginning a study in patients with AUD and a BMI greater than 30 kg/m2 to investigate the effects on alcohol intake of semaglutide up to 2.4 mg weekly (the maximum dose currently approved for obesity patients in the US)
Do not use the medication if it is cloudy, discolored, or contains particles
Understanding how long they may last is crucial for managing expectations and ensuring a safe and effective treatment
Weve started to see this now over and over again, says Drucker
Stick with the titration plan
Cruciferous vegetables like broccoli, cabbage, and Brussels sprouts are particularly problematic because they contain both FODMAPs and sulfur compounds that increase gas production through multiple pathways
